Consulting

NxR Biotechnologies (Nexar) is a consulting and investment firm assisting life science companies and academic institutions conducting business development or investment initiatives. Nexar provides services for performing strategic scientific and commercial assessments, technical writing, preparing business plans, gathering competitive intelligence, fund raising, and implementing partnerships and strategic alliances, divestitures, or commercialisation transactions.

Key focus areas include:

Pharmaceutical industry
Biotechnology industry
Regenerative medicine
Therapeutic stem cells
RNA therapeutics
Biologics and monoclonal antibodies
Industrial biotechnology
Sustainable and green chemistry

Technology assessment

Nexar helps companies conduct due diligence regarding the scientific and business merits of biotechnological innovation, using a proven analysis metrics.

Key due diligence filters include:

Innovativeness
Usefulness
Patentability
Manufacturability
Global market
Market penetration
Competitive landscape
Radical innovation vs. incremental innovation
Strategic fit

Partnering & Start-ups

Nexar conducts in the biotechnology arena divestitures and investments through implementing virtual teams. Linking key components to reach deep technology expertise and financial capabilities, Nexar builds upon its network of key opinion leaders and financial hourses to implement business and research projects in strategic or white space areas.

Key capabilities include: